At1g63070 Antibody

What is At1g63070 and why is it significant in plant research?

At1g63070 is a gene encoding a pentatricopeptide repeat (PPR) protein in Arabidopsis thaliana. PPR proteins play crucial roles in RNA processing, particularly in organelles such as mitochondria and chloroplasts. They are characterized by tandem arrays of a degenerate 35-amino-acid repeat motif and typically function in post-transcriptional processes including RNA editing, splicing, cleavage, and translation .

The significance of At1g63070 stems from its involvement in organellar gene expression regulation. PPR proteins like At1g63070 contribute to proper plant development, organelle biogenesis, and stress responses. Understanding their function requires specific antibodies for detection, localization, and interaction studies.

What methodological approaches are recommended for validating At1g63070 antibody specificity?

Validating antibody specificity for At1g63070 should follow multiple complementary approaches:

• Western blotting with recombinant protein: Compare detection of purified recombinant At1g63070 protein (as provided in commercial antibody kits) against plant extracts .

• Knockout/knockdown validation: The most rigorous specificity test is comparing wild-type plants with At1g63070 knockout or knockdown plants. Signal absence or reduction in mutants confirms specificity.

• Preabsorption test: Preincubate the antibody with excess purified antigen (like the 200μg antigens included in commercial kits) before immunodetection. Disappearance of signal indicates specificity.

• Cross-reactivity assessment: Test the antibody against closely related PPR proteins to ensure it doesn't cross-react with other family members.

• Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry to confirm the identity of the captured protein.

What applications are supported by current At1g63070 antibodies?

Based on available information, current At1g63070 antibodies support several key applications:

Each application requires specific optimization depending on plant tissue type, developmental stage, and experimental conditions.

How can researchers optimize subcellular localization studies using At1g63070 antibodies?

Optimizing subcellular localization studies for At1g63070 requires careful consideration of several methodological aspects:

• Fixation protocol selection: PPR proteins like At1g63070 may require specific fixation methods to preserve epitope accessibility. Compare paraformaldehyde (4%, 20 min) with glutaraldehyde (0.1-0.5%) fixation to determine optimal epitope preservation.

• Permeabilization optimization: Since At1g63070 is likely localized to organelles (potentially mitochondria or chloroplasts based on other PPR proteins) , permeabilization conditions must allow antibody access to these compartments. Test graduated series of detergent concentrations (0.1-0.5% Triton X-100) and durations.

• Co-localization markers: Include established organelle markers such as:

  • Mitochondria: COX2, ATP synthase

  • Chloroplasts: RbcL, PsbA

  • Nucleus: Histone H3

• Resolution considerations: For distinguishing between similar compartments (e.g., chloroplast envelope vs. stroma), super-resolution microscopy techniques such as STED or STORM may provide better resolution than conventional confocal microscopy.

• Signal validation: Include controls such as preimmune serum (provided in commercial kits) to establish background levels and knockout/knockdown lines to confirm signal specificity.

The systematic subcellular localization study of PPR proteins provides valuable methodology that can be adapted specifically for At1g63070 .

What approaches are recommended for studying At1g63070 protein-RNA interactions?

PPR proteins like At1g63070 typically function through protein-RNA interactions. Several methodological approaches can elucidate these interactions:

• RNA immunoprecipitation (RIP): Using validated At1g63070 antibodies , perform RIP followed by RNA sequencing to identify bound RNA targets. Critical steps include:

  • Crosslinking optimization (UV or formaldehyde)

  • Stringent washing conditions calibration

  • RNA integrity preservation

  • Appropriate negative controls (preimmune serum)

• Electrophoretic mobility shift assay (EMSA): Using recombinant At1g63070 protein and candidate RNA targets to assess direct binding in vitro.

• UV crosslinking studies: To identify precise binding sites through techniques like CLIP-seq (Crosslinking and Immunoprecipitation followed by sequencing).

• Structural studies: For researchers investigating binding mechanisms, techniques like hydrogen-deuterium exchange mass spectrometry can reveal conformational changes upon RNA binding.

• In vivo validation: Genetic complementation using wild-type and mutant versions of At1g63070 to correlate RNA binding with biological function.

These approaches should be used in combination to build a comprehensive understanding of At1g63070's RNA targets and binding properties.

How do experimental conditions affect At1g63070 detection by antibodies?

Several experimental variables can significantly impact At1g63070 detection:

• Extraction buffer composition: PPR proteins may associate with membrane structures. Test different extraction conditions:

  • Standard extraction: 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100

  • Membrane-optimized: Addition of 0.5% sodium deoxycholate

  • Organelle-focused: Include 0.1M sucrose and 5mM EDTA

• Reducing agent importance: Compare fresh DTT (5mM) vs. β-mercaptoethanol (0.1%) for preserving antibody recognition of At1g63070.

• Plant growth conditions: PPR protein expression may vary with:

  • Light conditions (intensity and duration)

  • Temperature stress

  • Nutritional status

  • Developmental stage

• Sample handling: Rapid processing at 4°C with protease inhibitors is essential to prevent degradation that could affect antibody recognition.

• Antibody storage and handling: Aliquot antibodies to avoid freeze-thaw cycles and store at -20°C or -80°C as recommended .

When troubleshooting detection issues, systematically test these variables while maintaining appropriate controls in each experiment.

What are the optimal Western blot protocols for At1g63070 detection?

The following methodological details are critical for successful Western blot detection of At1g63070:

• Sample preparation:

  • Extract proteins using a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 5mM EDTA, 5mM EGTA, protease inhibitor cocktail

  • Sonicate briefly (3 x 10s pulses) to disrupt organelles

  • Centrifuge at 14,000g for 15 minutes at 4°C

• Gel electrophoresis:

  • Use 10-12% SDS-PAGE for optimal resolution

  • Load 20-40μg total protein per lane

  • Include recombinant At1g63070 protein as positive control

• Transfer conditions:

  • Semi-dry transfer: 15V for 30 minutes

  • Wet transfer: 30V overnight at 4°C

  • Use PVDF membrane for higher protein binding capacity

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Primary antibody dilution: 1:1000 to 1:2000 in blocking solution

  • Incubate overnight at 4°C with gentle agitation

  • Secondary antibody (anti-rabbit IgG-HRP): 1:5000 for 1 hour at room temperature

• Detection optimization:

  • For low abundance detection: Use enhanced chemiluminescence-plus (ECL+) systems

  • For quantitative analysis: Consider fluorescent secondary antibodies and scanning systems

• Controls:

  • Positive control: Recombinant At1g63070 protein

  • Negative control: Pre-immune serum at the same dilution as the primary antibody

  • Loading control: Anti-Actin or anti-Tubulin antibodies

These parameters should be adjusted based on the specific antibody being used and the plant tissue being examined.

What considerations are important for immunoprecipitation of At1g63070?

Successful immunoprecipitation (IP) of At1g63070 requires attention to several methodological details:

• Antibody selection and coupling:

  • Use affinity-purified antibodies for higher specificity

  • Pre-couple antibodies to Protein A/G beads or directly to activated beads

  • Optimal antibody amount: 2-5μg per mg of total protein

• Extraction conditions:

  • Gentler lysis buffers to preserve protein interactions: 20mM HEPES pH 7.5, 150mM NaCl, 0.5% NP-40, 1mM EDTA, 10% glycerol, protease inhibitors

  • Consider crosslinking (1% formaldehyde for 10 minutes) to stabilize transient interactions

  • Include phosphatase inhibitors if studying phosphorylation status

• IP procedure optimization:

  • Pre-clear lysates with beads alone to reduce non-specific binding

  • Incubation time: 4 hours to overnight at 4°C with rotation

  • Washing stringency: Test graduated salt concentrations (150-500mM NaCl)

• Elution methods:

  • Gentle: Low pH elution buffer (0.1M glycine pH 2.5)

  • Denaturing: Boiling in 1X SDS sample buffer

  • For mass spectrometry: On-bead digestion

• Validation approaches:

  • Western blot of IP samples using the same antibody

  • Mass spectrometry analysis of immunoprecipitated proteins

  • Reverse IP with interacting partners if known

• Controls:

  • Negative control: Pre-immune serum IP

  • Input control: 5-10% of starting material

  • IgG control: Non-specific IgG from same species

These parameters should be optimized depending on the specific research question and downstream applications.

How can researchers resolve contradictory data regarding At1g63070 localization?

When facing contradictory localization data for At1g63070, implement a systematic approach:

• Methodological reconciliation:

  • Compare fixation methods used in different studies (chemical vs. cryofixation)

  • Assess antibody specificity verification methods

  • Evaluate microscopy techniques and resolution limits

  • Consider tissue-specific or developmental differences

• Independent validation approaches:

  • Fluorescent protein fusions (N-terminal and C-terminal)

  • Multiple antibodies targeting different epitopes

  • Biochemical fractionation followed by Western blotting

  • Proximity labeling techniques (BioID or APEX)

• Biological explanations for discrepancies:

  • Dual localization possibilities (some PPR proteins shuttle between compartments)

  • Dynamic localization based on cellular conditions

  • Isoform-specific localization patterns

  • Developmental stage-specific localization

• Statistical analysis:

  • Quantify localization across multiple cells (n>100)

  • Calculate co-localization coefficients with organelle markers

  • Report confidence intervals for localization claims

• Experimental conditions that may affect localization:

  • Light/dark transitions

  • Stress conditions

  • Nutrient availability

  • Cell cycle stage

The systematic localization study of PPR proteins provides a methodological framework for resolving such contradictions through standardized approaches.

What statistical approaches are recommended for quantifying At1g63070 expression?

Quantitative analysis of At1g63070 expression using antibody-based methods should follow these statistical guidelines:

• Western blot quantification:

  • Use linear range determination with dilution series

  • Normalize to appropriate loading controls (ACTIN, TUBULIN, or GAPDH)

  • Apply densitometry with background subtraction

  • Include technical replicates (n≥3) and biological replicates (n≥3)

  • Statistical tests: ANOVA with post-hoc tests for multiple comparisons

• Immunofluorescence quantification:

  • Measure mean fluorescence intensity across defined regions

  • Include signal-to-noise ratio analysis

  • Use Z-stack average projections for volumetric samples

  • Control for autofluorescence with unstained samples

  • Statistical analysis: Nested ANOVA to account for cell-to-cell variability

• ELISA quantification:

  • Generate standard curves using purified recombinant protein

  • Use 4 or 5-parameter logistic regression for curve fitting

  • Include plate-to-plate normalization with standard samples

  • Minimum sample size: n≥4 biological replicates

• Data presentation recommendations:

  • Box plots showing median, quartiles, and outliers

  • Include individual data points for transparency

  • Report effect sizes along with p-values

  • Provide clear descriptions of normalization methods

• Software tools:

  • ImageJ/Fiji for Western blot and immunofluorescence analysis

  • R or GraphPad Prism for statistical analysis

  • Consider blinded analysis to reduce bias

Following these approaches ensures rigorous quantification of At1g63070 expression while acknowledging the inherent variability in biological systems.

How should researchers approach investigating At1g63070 protein-protein interactions?

Investigating protein-protein interactions of At1g63070 requires a multi-faceted approach:

• Co-immunoprecipitation (Co-IP) with At1g63070 antibodies:

  • Use optimized IP protocols as described in section 3.2

  • Analyze by mass spectrometry for unbiased discovery

  • Validate specific interactions by reverse Co-IP

  • Include appropriate controls (pre-immune serum, IgG control)

• Proximity-based methods:

  • BioID: Fuse BirA* to At1g63070 for proximity biotinylation

  • APEX2: Peroxidase-based proximity labeling

  • Split complementation assays (BiFC, split luciferase)

• In vitro validation:

  • Recombinant protein pull-down assays

  • Surface plasmon resonance for interaction kinetics

  • Isothermal titration calorimetry for thermodynamic parameters

• Genetic approaches:

  • Suppressor/enhancer screens with At1g63070 mutants

  • Double mutant analysis with putative interactors

  • Synthetic lethality screens

• Functional validation:

  • Co-localization studies using dual immunofluorescence

  • Mutational analysis of interaction domains

  • Competition assays with peptides or small molecules

• Data integration:

  • Compare with published interactome datasets

  • Analyze co-expression patterns across conditions

  • Evaluate evolutionary conservation of interactions

This comprehensive approach allows researchers to build confidence in protein interaction data through multiple lines of evidence, rather than relying on a single method.

What emerging techniques might enhance At1g63070 research using antibodies?

Several cutting-edge techniques hold promise for advancing At1g63070 research:

• Single-cell antibody-based techniques:

  • Single-cell Western blotting for heterogeneity analysis

  • Imaging mass cytometry for spatial proteomic analysis

  • Microfluidic antibody-capture devices for low input material

• Advanced microscopy applications:

  • Live-cell immunolabeling with cell-permeable nanobodies

  • Super-resolution microscopy (PALM, STORM, STED) for precise localization

  • Lattice light-sheet microscopy for dynamic localization studies

• Proteoform-specific approaches:

  • Modification-specific antibodies (phosphorylation, ubiquitination)

  • Combined epitope targeting for distinguishing splice variants

  • Native protein complex preservation techniques

• High-throughput antibody applications:

  • Antibody arrays for protein interaction mapping

  • Multiplexed immunoassays for pathway analysis

  • Automated imaging and analysis pipelines

• Integrative methods:

  • Combined RNA-seq and antibody-based proteomics

  • Multi-omics approaches incorporating antibody-derived data

  • Systems biology modeling using quantitative antibody data

These emerging techniques could provide new insights into At1g63070 function, particularly regarding its dynamic behavior in response to environmental conditions and its role in coordinating gene expression between nuclear and organellar genomes.

How might CRISPR-engineered variants impact antibody-based At1g63070 research?

CRISPR/Cas9 technology offers new opportunities for antibody-based research on At1g63070:

• Epitope tagging at endogenous loci:

  • CRISPR knock-in of small epitope tags (FLAG, HA, V5) at the At1g63070 locus

  • Advantages: Can use well-characterized commercial tag antibodies

  • Methodological considerations: Validate that tagging doesn't disrupt function

• Variant-specific antibody applications:

  • Generate CRISPR-edited plants with specific domain deletions or mutations

  • Test domain-specific antibody recognition

  • Map functional domains through correlation of antibody reactivity and phenotype

• Multiplex genome editing implications:

  • Create plants with multiple edited PPR proteins

  • Use antibody panels to assess compensatory expression changes

  • Study protein complex reorganization after specific mutations

• Validation opportunities:

  • CRISPR knockout lines as negative controls for antibody specificity

  • CRISPR activation (CRISPRa) for testing antibody detection limits

  • Allelic series for antibody epitope mapping

• Functional genomics integration:

  • Combine CRISPR screens with high-throughput antibody readouts

  • Correlate genome-wide functional data with At1g63070 expression/localization

  • Synthetic biology approaches to rewire At1g63070 function

These approaches leverage the precision of CRISPR/Cas9 editing to enhance antibody-based research, providing new tools for understanding At1g63070 function in plant biology.